Tris Pharma and Pediatrix Therapeutics extend partnership for ADHD portfolio
Tris Pharma, Inc announced today (December 2) that they have expanded their partnership allowing Pediatrix Therapeutics to…
December 2, 2022 - 2 minutes
In Depth
Is an HIV Cure Possible? The Future of HIV Therapy
HIV research has come a long way since the virus was discovered in the 1980s.…
December 1, 2022 - 8 minutes
News and Trends
FDA’s approval of first fecal microbiota product, Rebyota, hailed an ‘enormous step forward’ for the field
The first fecal microbiota product, Rebyota, approved by the U.S. Food and Drug Administration (FDA)…
December 1, 2022 - 6 minutes
News and Trends
‘Best hope yet’ as results from Alzheimer’s drug trial reveal huge step forward
A huge step forward in dementia research has been hailed a truly historic moment by…
November 30, 2022 - 6 minutes
What's New
MorePartnership to deliver oncology workflow for 7 European hospitals
A BC Platforms (BCP) partnership that includes Finland’s Euformatics and Hungary’s Oncompass Medicine has been…
December 2, 2022 - 4 minutes
Creating designer immune cells at scale
To prevent testing on animals and create more precise ways of testing therapeutics, the pharmaceutical…
December 2, 2022 - 4 minutes
Full-Life Technologies acquiring Focus-X Therapeutics
Full-Life Technologies, a global radiotherapeutics company, is acquiring New Jersey-based Focus-X Therapeutics, a company developing…
December 2, 2022 - 2 minutes
Khondrion’s sonlicromanol produces encouraging results for next stage of study
Biopharma company, Khondrion, has marked announced improvements from patients with MELAS spectrum disorders taking its…
December 2, 2022 - 2 minutes
FDA clears SparingVision’s investigational new drug application to treat ocular diseases
SparingVision today announces that the U.S. Food and Drug Administration (FDA) has cleared its Investigational…
December 1, 2022 - 4 minutes
Five apps powering the future of at-home HIV tests
The smartphone revolution is providing a promising tool to combat the human immunodeficiency virus (HIV)…
December 1, 2022 - 8 minutes
Trial for HPV16 positive oropharyngeal cancer completes enrolment for phase 2
Netherlands-based ISA Pharmaceuticals B.V., has announced that it has completed enrolment in its phase 2…
December 1, 2022 - 2 minutes
FDA grants Sensorion Orphan Drug Designation for hearing loss drug
Sensorion a clinical-stage biotechnology company has announced that the US Food and Drug Administration (FDA)…
November 30, 2022 - 3 minutes
From Our Partners
View More
Sponsored
by ACROBiosystems
Supporting innovative drug development with full-length transmembrane protein platforms
Sponsored
by Merck
Infographic: your gene therapy manufacturing success recipe
Sponsored
by ACROBiosystems
Impacting vaccine development: COVID-19 and its implications for the future of vaccines
Sponsored
by CENTOGENE
Improving rare disease diagnosis and treatment with next generation sequencing technology
Download our industry reports
View all our reports
